Literature DB >> 17892427

Robotic-assisted laparoscopic radical prostatectomy: a report of the current state.

Vipul R Patel1, Ketul Shah, Kenneth J Palmer, Rahul Thaly, Geoff Coughlin.   

Abstract

Cancer of the prostate is the most common malignancy diagnosed in the male genitourinary tract. Although a number of treatment options are available for early prostate cancer, the gold standard of treatment remains retropubic radical prostatectomy. However, robotic-assisted laparoscopic radical prostatectomy (RALP) has become a forerunner in treatment options, yielding comparable medium-term perioperative and functional outcomes. For this our team utilized MEDLINE, searching for publications on perioperative and functional outcomes related to robotic prostatectomy. Robotic-assisted prostatectomy has allowed urologists to enter the realm of minimally invasive surgery by incorporating open surgery maneuvers into a laparoscopic environment. To date, RALP perioperative and functional outcomes are comparable to the gold standard; the collection of long-term data is needed in order to establish its true efficacy.

Entities:  

Mesh:

Year:  2007        PMID: 17892427     DOI: 10.1586/14737140.7.9.1269

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  3 in total

1.  Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer.

Authors:  Amerigo Pagoto; Francesca Garello; Giada Maria Marini; Martina Tripepi; Francesca Arena; Paola Bardini; Rachele Stefania; Stefania Lanzardo; Giovanni Valbusa; Francesco Porpiglia; Matteo Manfredi; Silvio Aime; Enzo Terreno
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

2.  High prostatic fascia release or standard nerve sparing? A viewpoint from Columbia University Medical Center.

Authors:  Ketan K Badani
Journal:  J Robot Surg       Date:  2008-08-28

3.  Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.